While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. 8 million shares. 79 as the 52 week high point — that compares with a last trade of $126. The fund tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. XBI Looks. 61%) At close: 04:00PM EST Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. In addition to holding 155 positions, its top 10 holdings make up just 14. 40 for Nov. 65%. Performance. 94 per share, with $121. Both XBI and XLV are ETFs. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 11. The top holdings of these ETFs are Exact Sciences Corp. That's the main advantage to investing. Its fund flows were negative $259. The vast majority of XBI holdings have less than a 1% allocation in the fund. Holdings AS OF 04/30/2023. Dividend Yield. Top 10 Holdings (16. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). XBI vs ARKG. $0. 2% weight, and there are 133 holdings in total in the fund (Figure 1). $0. The vast majority of XBI holdings have less. Overview. The ETF has lost about -12. **Close price adjusted for splits and dividend and/or capital gain distributions. View Holdings As of 09/30/2023. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. 66% so far this year and in the past. Before you invest in the SPDR ® S&P Biotech ETF (the “Fund”), you may want to review the Fund's prospectus and statement of additional information, which contain more information about the Fund and the risks of investing in the Fund. The equal weight fund, designed to deliver. LABU has a lower 5-year return than XBI (-46. 73m. Holdings. 1% and 1. 42 billion worth of net assets. 88%. The top ten holdings in IBB make up 51% of the fund, while the top ten in XBI only account for 12% of the fund. ETF Channel Staff - Friday, October 20, 6:48 AM. 45% vs 0. Vertex Pharmaceuticals (VRTX 0. 31, 2021, are" XBI is an equal weight fund that rebalances each quarter. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. We daily evaluate future near-term price gain prospects for quality, market-seasoned ETFs, based on the expectations of market. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. $6. While I love Cathie Wood, I just don't see how she can keep this up. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. With XBI trading at a recent price near $131. XBI is an almost pure play on the biotechnology sector. Per cent of portfolio in top 5 holdings: 8. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. ARKG vs XBI Fund Comparison . Lucy Brewster | Nov 10, 2023. Holdings. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. Holdings. Stock Analysis Chart Headlines Holdings Ownership Ratings. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. Comparing the most. 78%) has been the biggest winner, with its shares jumping nearly 40% year to date. The XBI holdings are quite variable probably helped by algos. 67. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 49% weight in the XBI, are bumping into the $164 head resistance and are. SPDR S&P Biotech ETF ETF holdings by MarketWatch. Below is the comparison between VHT and XBI. Follow. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P. Please call us for more information - (250). News, commentary and events are from third-party sources unaffiliated with Fidelity. 1. 🇺🇸. IBB has 8. Complete SPDR S&P Biotech ETF funds overview by Barron's. Seeks to track a modified. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. XBI has a higher expense ratio than XLV (0. 86% so far this year and is down about -32. The company has an 88. 26 during this last 52-week period. Top Ten Holdings as of 10/31/2023 Top 10 Holdings in XBI 16. 64 billion, a PE ratio of 11. Learn everything about iShares Biotechnology ETF (IBB). Viehbacher reported, “In the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimer’s disease and ALS, while also delivering on our. 06 and standard deviation of 38. 56% vs 0. 35%). 9%. Fund Analysis. According to data from U. 54%. 01 to $0. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). N/A. 0. Jun 8, 2022 10:51AM EDT. View complete XBI exchange traded fund holdings for better informed ETF trading. Further, the fund owns $6. 58 💸. RGLD. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 06 as the 52 week high point — that compares with a last trade of $109. ETFs are subject to market fluctuation and the risks of their underlying investments. The weighted harmonic average of closing market price divided by. Find Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) top 10 holdings and sector breakdown by %. 98 and standard deviation of 40. Comparing XBI with other biotech ETFs, we note that XBI is one of the largest with around US$8 billion in assets under management and has one of the lowest expense ratios at 0. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. 35% Expense Ratio 20 40 60 per page Viewing 1-20 of 134 matches 1 2 3 4 5 XBI: SPDR S&P Biotech ETF - Fund Holdings. 40. by Sweta Killa Published on September 18,2023. 84%: Other: 0. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. 16bn USD. 44 per share, with $92. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment Research Learn everything about SPDR S&P Biotech ETF (XBI). 7657M. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style, stock holdings and more. ($423. S. The weighted harmonic average of closing market price divided by. XBI Description. 42 billion worth of. XBI is suitable for investors seeking to. Holdings AS OF 04/30/2023. The XBI index methodology takes market cap and share liquidity into account in rebalancing holdings. 5x and PE ratio is about 14x. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. XBI Holdings (Seeking Alpha) Risks. Holdings; Holdings Overlap; Attribution; Fundamental Chart; Scatter Plot; Tech Chart; Stress Test; ESG; Data; More. NAV as of Nov 16, 2023. $6. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Year-to-date, the SPDR S&P Biotech ETF has lost about -15. 2 %. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare . Further, the fund owns $6. XBI has traded between $73. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. XBI. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. 87. XBI has a beta of 0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 18. 10 as of November 2, 2022. 15 billion assets under management. In addition to holding 155 positions, its top 10. S. N/A. 01% vs 8. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Meanwhile, XBI equal weights its holdings. 40. The company’s fifty day. -listed equities in the biotechnology sector. Performance and Risk So far this year, XBI has added roughly 1. Looking at the chart above, XBI's low point in its 52 week range is $62. 2. VICTORIA, BC / ACCESSWIRE / September 27, 2023 / Boron One Holdings Inc. Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. Top 10 Holdings XBI. com if you have any further questions. " The 12-month stock price forecast is $22. , and Amgen Inc. 12 and $91. Looking at the chart above, XBI's low point in its 52 week range is $61. Trader's Guide 2024 Ships December 21st. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. 5% position, and no other holding accounts for more than 1. Top Holdings . XBI SPDR S&P Biotech ETF Price: undefined undefined Change: Category: Health & Biotech Equities Last Updated: Nov 21, 2023 Vitals Issuer State Street Brand. 35%. 2015. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. S&P Select Industry Indices are designed to measure the performance of narrow GICS® sub-industries. XBI focuses on a narrow sector of the health care sector, and as such is probably too precise for most investors. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. 22%: Revolution. The fund has a beta of 0. IBB vs. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P. The 10 largest holdings have a combined 17. Below is the comparison between ARKG and XBI. 37% in the last one. Holdings. 81 and $97. 47% vs -5. 80 per share, with $92. The top holding in XBI receives just a 1. 22% of total assets) As of November 16, 2023. With about 156 holdings, it effectively. The beaten-down prices offer a solid buying opportunity for investors. Latest SPDR® S&P Biotech ETF (XBI:PCQ:USD) share price with interactive charts, historical prices, comparative analysis, forecasts,. 46% YTD Daily Total Return ETF Summary. 97. IBB's and XBI's Top Holdings are About to Break Out. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. Warren Buffett is known for holding onto his S&P 500 stocks forever. Both IBB and XBI are ETFs. 50. For an investor to take. 264,458,476. 88 ; Annual Dividend & Yield 0. Health Care Fund Highlights: 137 Total Holdings $5. 97 and standard deviation of 36. Skip to main content. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). The company’s fifty day. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. View Holdings As of 09/30/2023. Latest Holdings, Performance, AUM (from 13F, 13D) XBI - SPDR (R) S&P (R) Biotech ETF has disclosed 142 total holdings in their latest SEC filings. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. 51 on Tuesday. Its fund flows were negative $259. Components of. 23%) Advertisement SPDR S&P Biotech ETF (XBI) NYSEArca - NYSEArca Delayed Price. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. 35%). Its price to cash flow multiples is about 13. Below is the comparison between VHT and XBI. 01 to $0. 73% so far this year and is down about -39. Track SPDR Biotech ETF (XBI) Stock Price, Quote, latest community messages, chart, news and other stock related information. com. 191), IBB is significantly more concentrated in its top ten holdings than XBI. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. Neena Mishra May 10, 2023. The current portfolio value is calculated to be $6. Themes & Subsectors ETFs. As of 09/30/2023. 96%, and is down about -5. As you can see from our holdings in the first chart, we have a sizable exposure to both the ProShares UltraPro QQQ ETF ( NASDAQ: TQQQ) and SPDR S&P Biotech ETF ( NYSEARCA: XBI ). Mean reversion is inevitable, and her ARKG fund was up something like 300% in 2020 (it was absolutely killing the market for a few years before then too). In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. Some of the top XBI holdings continue to defy the bear market. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. 12% in the last one year (as of 03/16/2023). 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. 16. The company has an 88. 35 %LABU: S&P Biotech Bull 3X Shares ETF:Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron . While this ETF allocates. ("Boron One" or the. XBI's 120. All 33 ARKK ETF Holdings. 10% of. Its top 10 holdings account for approximately 16. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. ARKK ARKG. Netherlands. $5. Better trading starts here. ARGX. 9%. During this past 52-week period, the fund has traded between. SPDR S&P Biotech ETF is a equity fund issued by SSgA. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Cash and Equivalents. 39. ARKK Holdings / CRSP / ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily. 86 Prior Close 70. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. (“SSGA FM” or the “Adviser”), the investment adviser to the Fund, either may invest the Fund's assets. Name Symbol % Assets. 86% so far this year and is down about -32. 0. 99%. Top 10 Holdings. The fund has a beta of 0. 60 as the 52 week high point — that compares with a last trade of $69. News & World Report, XBI enjoys volume of 20. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. Top 10 Holdings (14. 53 (3. These are the positions, trades, and weight of all companies in her ARKK Innovation ETF. 61%) 13,857,540 Average : As of close 11/17/2023: Summary; News; Charts;. XBI has an overall POWR Rating of D, equating to a Sell. ETF Strategies. 35%). Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. . 81. 03 per $1,000 of principal). Advertisement. Mirati. ETFs are subject to market fluctuation and the risks of their underlying investments. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. No single stock makes up even 1% of XBI's overall holdings. NEW: Experience our best charts yet. S. Holdings. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 90 in this past 52. XBI has a beta of 1. 72%: Data delayed at least 15 minutes, as of Nov 16 2023 21:00 GMT. 7% of assets. Total net assets. 79 as the 52 week high point — that compares with a last trade of $159. Performance and Risk. 1. SPDR S&P Biotech ETF Stock Up 1. XBI: SPDR S&P Biotech ETF - Fund Holdings. Compare ETFs XBI and IBB on performance, AUM, flows, holdings, costs and ESG ratings. Like IBB, XBI uses diversification to. 94 per share, with $116. 9. SPDR S&P Biotech ETF Stock Up 1. ETFs are subject to market fluctuation and the risks of their underlying investments. Net Expense Ratio. 78% in the last one year. 17. 66 +2. Compare ETFs IBB and XBI on performance, AUM, flows, holdings, costs and ESG ratings. 77. All 142 XBI Holdings. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. 250-590-1718. Asset type. by Sweta Killa Published on September 18,2023. 97. 01%). The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Boron One Announces First Closing of Financing. Stock Analysis Chart Headlines Holdings Ownership Ratings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. Free ratings, analyses, holdings, benchmarks, quotes, and news. 96%, and is down about -5. XLY News. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. 84. 38%. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. SPDR® S&P Biotech ETF (XBI) latest earnings report: revenue, EPS, surprise, history, news and analysis. 50(-0. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. Dollar Tree Inc. Implied XBI Analyst Target Price: $135. Below is the comparison between BBH and XBI. . Nov 20, 2023Top 10 Holdings. Jun 23, 2022 10:49AM EDT. View complete XBI exchange traded fund holdings for better informed ETF trading. As of 9/30/23. 5% on the day. SGEN. N/A. LABD. 79 as the 52 week high point — that compares with a last trade of $133. Share class size. 20. By Holdings Channel Staff, updated Friday, November 3, 9:50 AM In total we count 672 hedge funds holding XBI as of their latest 13F filing, but among those we've sorted out just the top ten hedge funds holding XBI by largest position size, and presented them here in slideshow format. More XBI Holdings Current Portfolio Date Nov 16, 2023; Equity Holdings 132; Bond Holdings 0;During the previous two years, 872 institutional investors and hedge funds held shares of SPDR S&P Biotech ETF. In contrast, most. The Composition of the XBI is the Key. ARGX. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 57 billion. 83%: Other: 0. 35% for XBI, but SBIO yields 2. The weighted harmonic average of closing market price divided by. Fund size is a good indication of how many other investors trust this fund. XBI has traded between. 94 per share, with $174. 51. For an ETF, this widget displays the top 10 constituents that make up the fund. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. SPDR® S&P Biotech ETF. 1005 Broad St 5 Victoria BC V8W 2A1. Investo S&P Biotech Sel Industry ETF IE. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. View complete XLP exchange traded fund holdings for better informed ETF trading.